Defunct Company
Total Trials
11
As Lead Sponsor
8
As Collaborator
3
Total Enrollment
1,255
NCT00005091
DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 28, 1999
Completion: Aug 31, 2003
NCT00325390
Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation
Phase: Phase 3
Role: Collaborator
Start: Jul 31, 2004
Completion: Not specified
NCT00221091
Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure Hydrocephalus
Start: Sep 30, 2004
Completion: Oct 31, 2005
NCT00682760
Comparison of Korean Botulinum Toxin Type A Versus Botox in the Treatment of Essential Blepharospasm
Start: Oct 31, 2005
Completion: Aug 31, 2006
NCT00366119
Safety and Efficacy of Ramipril in the Treatment of Essential Hypertension
Phase: Phase 4
Start: Jun 30, 2006
Completion: Jun 30, 2007
NCT00841854
Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication
Start: Jun 30, 2008
Completion: Nov 30, 2010